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Background/aim: The survival of autologous fat graft tissue is dependent on various factors such as vascularization and inflammation.
The aim of the present study was to evaluate the possible beneficial effects of low-dose methotrexate (LD-MTX) on fat graft volume and
survival.
Materials and methods: A total of 13 male Wistar albino rats were divided into two groups, a control group and an LD-MTX
group. An autologous fat graft obtained from the inguinal region of each rat was transferred to its back. LD-MTX was administered
intraperitoneally in the LD-MTX group once a week for 4 weeks after the surgical procedure. The control group underwent surgery but
was not administered MTX. Fat grafts were harvested for analyses.
Results: The results showed that 2 months postoperatively the fat graft weights of the control and LD-MTX groups were not significantly
different. In addition, the vascularity of the grafts was higher in the LD-MTX group than it was in the control group. The mean lipid
peroxidation levels were essentially the same in the two groups, but myeloperoxidation was significantly lower in the LD-MTX group
than it was in the other group.
Conclusion: The results showed that LD-MTX administration may not preserve the quality and volume of transplanted fat tissue in rats.
Key words: Fat graft, fat graft survival, methotrexate

1. Introduction
Fat tissue, which is nontoxic, nonallergic, and simply
harvested, is confirmed as an ideal autologous soft tissue
filler (1,2). It can be used in several procedures such as
facial aesthetic surgery, body contouring, scar revisions,
and velopharyngeal insufficiency (3,4). However,
unpredictable long-term survival is a disadvantage of this
natural tissue because the grafted fat tissue frequently
encounters inflammation, ischemia, and apoptosis in
the recipient area (5). To solve this problem, vascular
endothelial growth factor (VEGF) (6), platelet-rich
plasma (7), and platelet-rich fibrin (7) have been used in
autologous fat tissue transfers to increase the vascularity of
the fat graft. Additionally, antitumor necrosis factor alpha
(anti-TNF-α) and washing of the fat graft could decrease
inflammatory mediators and have been used to prevent
inflammation of the transplanted fat graft (8).
Low-dose methotrexate (LD-MTX) has become
popular in the treatment of inflammatory diseases such
* Correspondence: drelifsanli@hotmail.com

as rheumatoid arthritis and graft-versus-host diseases,
since it has been demonstrated that LD-MTX can reduce
the destructive effects of the leukocytes and inhibit
proliferation of the lymphocytes at the inflammatory site
(9). The immunomodulatory effects of LD-MTX are related
with increasing adenosine levels in the inflammatory area.
High levels of adenosine inhibit the production of TNF-α,
interleukin 1 (IL-1), IL-6, IL-8, interferon gamma (IFN-ɣ),
superoxide, and nitric oxide (10). Furthermore, adenosine
is a cytoprotective molecule due to decreasing toxic oxygen
metabolites (11).
The aim of this experimental study was to investigate
the possible beneficial effects of LD-MTX on fat graft
survival.
2. Materials and methods
2.1. Materials
All the experimental animals were handled according to
the guidelines of the care and use of laboratory animals
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as stated by the Ankara Education and Research Hospital
Experimental Animal Laboratory Ethical Committee
(Number: 0015 / 229).
A total of 13 male Wistar albino rats weighing between
250 and 300 g were taken for the study. Methotrexate
(MTX; Koçak Farma 50 mg/5 mL, İstanbul, Turkey) was
used in this study. Its intraperitoneal LD50 is 6 mg/kg in
rats.
Anesthesia was performed with an intraperitoneal (IP)
administration of 40 mg/kg ketamine HCl (Ketalar; Pfizer
Inc., USA) and 5 mg/kg xylazine HCl (Rompun 2%; Bayer
HealthCare AG, Germany).
The animals were divided into two groups randomly:
- Control group (only fat transplantation was
performed and no experimental drug was administrated
to the rats) (n = 6),
- LD-MTX group (0.01 mL of methotrexate dissolved
in 0.09 mL of saline was administered intraperitoneally
once a week for 4 weeks) (n = 7).
2.2. Surgery
After ketamine HCl and xylazine HCl induced anesthesia,
the animals were placed in a supine position. The left
inguinal area of the rat was cleaned with betadine solution.
No local anesthetic or adrenaline was injected before the
fat dissection. An oblique 3-cm incision was made to the
left inguinal area (Figure 1). The fat tissue dissected from
the inguinal area was excised, dried with sterile gauze,
and weighed with a precision scale (Shimadzu AX-200,
USA) before the transfer. The value of each fat graft weight
obtained from the inguinal area (i.e. in the time period
called ‘before’) was noted separately. After the removal
of the fat grafts, the inguinal incision was sutured with
2/0 silk and the animals were placed in a prone position.

After cleaning the surgical field with betadine solution, a
1-cm incision was made to the dorsal interscapular area
and a 1 × 1 cm pocket was prepared over the panniculus
carnosus for fat grafts (Figure 1). The harvested autologous
fat tissues were washed with saline and cut into pieces
approximately 2–4 mm in length in all dimensions with
microscissors, and then each autologous fat graft cut into
pieces was inserted into the pockets (6). The LD-MTX
group was administered 0.01 mL of methotrexate diluted
in 0.09 mL of saline intraperitoneally once a week for 4
weeks; the control group was not administered any drugs.
Two months after the fat grafting, all animals were
resedated by the same procedure and they were sacrificed
using the cardiac air embolization technique. The fat grafts
were then removed carefully from the recipient pockets
and dried. Each fat tissue was weighed again with the same
precision scale and the results (i.e. for the time period
called ‘after’) were noted. The fat graft that was harvested
from each animal was then divided into two equal
portions: half of the specimen was put into 10% buffered
formaldehyde for histopathological examination, and the
remaining half was immediately stored at –30 °C in dry air
for biochemical evaluation.
2.3. Histopathological analysis
For histopathological examination, all tissue samples
were fixated in 10% buffered formaldehyde and processed
according to the routine light microscopic tissue
processing technique. Serial sections of 5 µm in thickness
stained with hematoxylin and eosin were examined and
photographed. Images were obtained with a digital camera
connected to a microscope equipped with an automatic
scanning table (DSRi1, Nikon’s inverted Eclipse Ti, Nikon
France S.A., France). The area of adipocytes in each group

Figure 1. The surgical procedures. (A) An incision was made to the inguinal region to obtain the fat graft. The photographs
reveal the fat graft before removal from the (B) control group and the (C) LD-MTX group, respectively.
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was measured separately using 40× magnification of the
graft by using a software program (Nikon NIS- Elements
Advanced Research (AR), version 4.0, Nikon Instruments,
Japan). A total of 5 random fields were examined, totaling
25 points per slide. The total areas of the adipocytes and
fibrotic areas were calculated as an average per rat. The
percentage rate of fat tissue area compared with the total
microscope viewing area was calculated. This ratio was
defined as the relative adipocyte index (Figure 2). The
vessel count was done using a microscope (Olympus
BX50) to view a 10× magnification of the graft, and the
total vessel number (i.e. vascularity level) was calculated
for each rat. A total of 4 random fields were examined,
totaling 20 points per slide. Inflammation degree was
measured by an inflammation scale (Table 1). Fat necrosis
was another histological parameter determined with the
same microscope as presence of fat necrosis (point 1)
or absence (point 0) subjectively. All specimens were
evaluated by an experienced histopathologist (ÖB) blinded
to the study groups and experimental material.
2.4. Biochemical analysis
Myeloperoxidase (MPO) and lipid peroxidase (LPO) levels
of the fat graft tissues obtained from the dorsal pockets of the
animals were measured by spectrophotometry (Shimadzu
UV-1700 Spectrophotometer) (12,13). All specimens were
evaluated by an experienced biochemist (BS) blinded to
the study groups and experimental material. Biochemical
analyses were performed with a thiobarbituric acid
application and then 532 nm spectrophotometry was used
to measure the LPO levels in nanomoles per gram of wet
tissue. Tetramethylbenzidine was applied to the tissues
and then 655 nm spectrophotometry was used to measure
the MPO levels calculated as units per gram of wet tissue
according to the amount of absorbance change (12,13).
2.5. Statistical analysis
Statistical analyses were performed using the SPSS 17.0.
A normality test was performed in the beginning of the

statistical analysis. The results that were normally distributed
and homogeneous variations were statistically analyzed by
an independent-samples t-test. Nonnormally distributed
results and nonhomogeneous variations were analyzed by
the Mann–Whitney U test. Furthermore, a paired-samples
t-test was performed to determine the statistical differences
between the fatty tissue weight values for each group.
3. Results
The values of the fat graft weights ‘before’ and ‘after’,
the vascularity level of ‘after’, and the LPO level values
of ‘after’ were normally distributed and variations were
homogeneous between the groups. Therefore, they were
statistically analyzed by an independent-samples t-test.
The tests revealed that the inflammation grade, fat necrosis
grade, fibrotic area level, adipocyte index percentages,
and tissue MPO level values of ‘after’ were not normally
distributed and the variation was not homogeneous between
the groups. Therefore, these values were analyzed by use of
the Mann–Whitney U test. Furthermore, a paired-samples
t-test was performed to determine the statistical differences
between the fatty tissue weight values of ‘before’ and ‘after’
for each group.
3.1. Macroscopic findings
Upon macroscopic inspection, no local inflammation
or abscess was observed at the surgical areas, and the
vascularities of the control and LD-MTX groups were
almost the same. The preserved fat tissue volumes were also
almost equal in both groups. During the sample collection
period, a fibrous capsule formation, which separated the
grafted fat tissue from the adjacent soft tissue, was observed
around all graft tissues (Figure 1).
3.2. Light microscopy
Upon light microscopy, there was evident vascular
congestion in the LD-MTX group. However, inflammation
grades and viable adipocyte distributions were similar in
both groups (Figure 2).

Figure 2. Histopathological measurement method of the relative adipocyte index in the two groups. A dense
vascularization of the graft tissue can be easily seen in the LD-MTX group.
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Table 1. Histopathological inflammation scale for the detection of inflammation levels of the groups.
Grade

Description

Grade 0

No inflammation or a few scattered lymphocytes.

Grade 1

One small group of lymphocytes (10–20).

Grade 2

One large group of lymphocytes ( >20), or two small groups.

Grade 3

Diffuse lymphocyte infiltration or more than one large group of lymphocytes.

3.3. Fat graft weight values
Fat graft weight values were compared both between the
groups and inside of each group. At the beginning of the
experiment (‘before’), there was statistically no difference
between the groups for the weight of the fat graft obtained
from the inguinal region of the rat (P = 0.072). At the
end of the study (‘after’), the weight values of the fat graft
were again not statistically different between the groups
(P = 0.098) (Tables 2 and 3; Figure 3). However, when the
mean values of the fat graft weights of the two groups were
compared, the values of ‘before’ were significantly different
from those of ‘after’ in the control group (P = 0.046) and in
the LD-MTX group (P = 0.008) (Table 3).
3.4. Histopathological findings
The fibrotic tissue diameter values around the fat grafts (P =
0.775), inflammation grade values (P = 0.876), fat necrosis
values (P = 0.409), and adipocyte index percentage values
(P = 0.775) were not significantly different between the
groups (Tables 2 and 4; Figure 4). However, the vascularity
level values were statistically significantly higher in the

LD-MTX group than the control group (P = 0.007) (Tables
2 and 5; Figure 4).
3.5. Biochemical findings
LPO level values were not statistically different between
the groups (P = 0.273), although the MPO level values
were statistically significantly lower in the LD-MTX group
than the control group (P = 0.022) (Tables 4 and 6; Figure 5).
4. Discussion
LD-MTX was recently reported to be an inhibitor of
lymphocyte proliferation and the destructive capacity
of leukocytes that reach the inflammatory area (14). It
also promotes extracellular adenosine accumulation at
the inflammatory site, which inhibits some cytokines,
superoxide, nitric oxide, and TNF-α (14,15). Adenosine
is a cytoprotective molecule due to its inhibitor effect
on toxic oxygen metabolites created from the adhesion
of stimulated neutrophils to the endothelium (11,16).
Decreasing the inflammation and apoptosis at the fat graft
area is a recently investigated method to increase long-

Table 2. Descriptive table of the fat graft weights, inflammation grade, fat necrosis grade, vascularity
level, fibrotic area, and adipocyte index values of each group (N: number of cases, SD: standard
deviation).
Groups
Control

LD-MTX
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Time

N

Mean

SD

‘Before’ weight value

6

0.446

0.18

‘After’ weight value

6

0.198

0.09

Inflammation level

6

1.17

0.98

Fat necrosis level

6

0.33

0.52

Vascularity level

6

27.43

6.25

Fibrotic area

6

588,489.83

448,611.56

Adipocyte index

6

79.26

15.82

‘Before’ weight value

7

0.679

0.23

‘After’ weight value

7

0.337

0.17

Inflammation level

7

1.00

0.82

Fat necrosis level

7

0.57

0.53

Vascularity level

7

45.41

12.02

Fibrotic area

7

463,778.51

140,894.40

Adipocyte index

7

83.67

4.95
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Table 4. This table reveals that the fibrotic tissue diameter values
around the fat grafts, inflammation grade values, fat necrosis
values, and adipocyte index percentage values did not differ
statistically between the groups. On the contrary, MPO levels
were significantly lower in the LD-MTX group than in control
group (Z = Z score of the statistical analysis).
Variable

Z

P

Inflammation level

–0.157

0.876

Fat necrosis level

–0.825

0.409

Fibrotic area

–0.286

0.775

Adipocyte index

–0.286

0.775

MPO

–2.286

0.022

P < 0.05.
Figure 3. The mean values of the fat graft weights of the LD-MTX
group compared to the control group. Each error bar shows the
minimum and maximum of the fat graft weight values.

term fat graft survival (5). Yang et al. evaluated the TNF-α
antibody in fat transplantation and found that anti-TNF-α
could be effective in increasing the fat graft survival due to
its antiapoptotic and antinecrotizing effects (8). Based on
these findings, we investigated the influence of LD-MTX
on fat graft survival.
In the present study, the fat graft weight values of both
groups were similar for ‘before’ and ‘after’. However, at the
end of the study, the mean value of ‘after’ was lower than
the mean value of ‘before’ for each group. Unfortunately,
these results may suggest that LD-MTX administered
intraperitoneally is not effective in preserving the graft
volumes.
To the best of our knowledge, the effect of LD-MTX
on vascularity of soft tissues has not been investigated
in the literature yet. In the present study, the vascularity
level values were higher in the LD-MTX group than
they were in the control group. Perhaps LD-MTX may
have a positive effect on growth factors (such as VEGF)
that enhance fat graft vascularization. However, more
Table 3. This table demonstrates that the fat graft values of the
‘before’ tests were significantly statistically different from the
‘after’ tests’ values in both groups
Group

P

Control

0.046

LD-MTX

0.008

P < 0.05.

detailed studies should be done to support this hypothesis.
Chronstein et al. (9) showed that LD-MTX can inhibit
proliferation of lymphocytes and activity of leukocytes.
However, adipocyte index, inflammation, and fat necrosis
values were not significantly different between the groups
in our study. According to these results, it can be argued
that vascularization alone is not sufficient to increase the
fat graft survival.
Fat graft loss is caused by the development of hypoxic
and ischemic conditions because of the decreased vascular
supply around the free fat graft tissue (17–20). Hypoxia
generates potent oxidizing species (e.g., superoxide
radicals, hydroxyl radicals, and hydrogen peroxide), which
mediate the lethal cell injury by initiating the peroxidative
decomposition of phospholipids, both in the cellular
and the mitochondrial membranes. MPO activity was
previously shown to correlate with the absolute number
of phagocytes and their activation in the inflamed tissue.
Neutrophils and other phagocytes (e.g., macrophages)
produce hypochloride, a strong oxidant that acts on
hydrogen peroxide and chloride ions during MPO (21,22).
LPO plays an important role in the pathogenesis of lethal
cell injury by degrading cellular and mitochondrial
membranes (22). It was demonstrated in the literature that
LD-MTX has different effects on LPO levels in different
studies (23,24). However, these studies were about spinal
cord injury. The biochemical findings of the present study
revealed that LD-MTX could not decrease the LPO levels
in fat graft tissue. Although this study did not employ
more specific biochemical analysis methods (such as
measurements of nitric oxide, glutathione, superoxide
dismutase levels, etc.), this result may mean that this
material cannot decrease the free radicals and their
destructive effects in fat grafts in rats.
There are different results about the effect of LD-MTX
on MPO levels in the literature. Although LD-MTX could
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Figure 4. Inflammation, fat necrosis, vascularity, fibrosis levels, and adipocyte index values of the LD-MTX group compared to the
control group. Each error bar shows the minimum and maximum values of the vascularity and fibrotic area diameter. Each bar shows
the inflammation level and fat necrosis.

not affect the MPO levels in spinal cord injury according
to the study of Bakar et al. (23), MPO levels were decreased
in another study about spinal cord injury (24). However,
it did lead to a decrease in the MPO levels in the LDMTX group in the present study. This may mean that
LD-MTX could decrease or block the myeloperoxidase
enzyme activation originating from the lysosomes of the
inflammatory cells. However, the lipid peroxidation level
values were not statistically different between the groups
and the fat graft weight volumes could not support this
theory.
Table 5. This table shows that only the vascularity level values
were statistically different between the groups.

Our study has some limitations. First, more
sophisticated biochemical analyses used to identify the
inflammatory pathways that influence fat graft survival
and volume (e.g., apoptosis, glutathione and nitrite/
nitrate levels, and oxidase activity) were not possible in our
laboratory. Thus, the mechanism of the effect of LD-MTX
on LPO and MPO cascades remains to be determined.
Second, excised and aspirated adipose tissues have
different characteristics in clinical practice (25). Therefore,
aspirated fat tissue with vasoconstrictor solutions can
be evaluated in future studies. Third, saline was not
Table 6. Descriptive table of the biochemical analyses findings of
each group (LPO: lipid peroxidation; MPO: myeloperoxidation;
SD: standard deviation; N: number of cases).

Variable

P

‘Before’ weight value

0.072

Groups

Variable

N

Mean

SD

‘After’ weight value

0.098

Vascularity level

0.007

Control

LPO

6

46.237

11.70

LPO

0.273

MPO

6

41.267

53.56

LPO

7

63.847

35.56

MPO

7

6.557

5.11

P < 0.05.
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Figure 5. The main values of the lipid peroxidation and myeloperoxidation level of the LD-MTX group compared to the
control group. Each error bar shows the minimum and maximum values of lipid peroxidation and myeloperoxidation level.

administered intraperitoneally to the control group in our
study. Therefore, the effect of the stress hormones could
not be eliminated in our study.
In conclusion, although LD-MTX could increase the
vascularization of transplanted fat tissue and decrease the

MPO levels, it could not adequately protect the fat graft
from resorption. However, further detailed studies in
larger animal groups could be done in the future.
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